Healthtech Startups

BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.

1 investor

BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods. The company conducts comprehensive biomarker assays and works with clinicians and researchers.

1 investor

BioClinique operates a network of medical laboratories providing clinical testing services across the Île-de-France region in France.

1 investor

Endobits is clinical decision-support software that runs on top of FDA-cleared continuous glucose monitors to help qualified healthcare professionals and clinics manage glucose-related conditions such as dysglycemia and pre-diabetes. The software supports clinician-directed care and references CPT codes for billing, while providers retain full clinical authority.

1 investor

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.

1 investor

BioDefense makes portable sensors that detect pathogens at the point of sampling in food and water. The devices test for several targets at once and return results in roughly 15 minutes, which shortens the wait associated with sending samples to a laboratory. Customers are industrial food and water operations managing contamination risk.

1 investor

Bio Design Lab uses synthetic biology to engineer viral vector components, offering retroviral and lentiviral vectors designed to shift transgene integration away from proto-oncogenes for improved safety and enhanced transduction efficiency. Its vectors support gene therapies, cell therapies (including T and NK cells), vaccine platforms, and protein-producing cell lines.

1 investor

Biodesix is a diagnostic solutions company that develops and provides advanced diagnostic tests, with a focus on lung disease and cancer, to support clinical decisions and personalized patient care. It also offers custom diagnostic development services to biopharmaceutical, life sciences, and research institutions.

1 investor

BioDigital builds an interactive 3D software platform for visualizing human anatomy, diseases, and treatments, with a cloud model library of over 14,000 anatomical structures and 600+ health conditions. It serves health education and life sciences organizations with tools for authoring custom anatomy experiences and 3D quizzes.

1 investor

Biodimension develops tissue engineering and non-animal testing methods including in-vitro platforms, biofabricated tissues, and computational models for pharmaceutical, personal care, and agrochemical industries. The company provides alternatives to animal testing for preclinical research and regenerative medicine applications.

1 investor

BioDlink is a contract development and manufacturing organization (CDMO) providing drug development and manufacturing services for biopharmaceutical companies, with specialization in antibody-drug conjugates (ADCs).

1 investor

Bioemtech provides in vitro cell-based assays and laboratory services for drug discovery and stem cell therapy applications, utilizing cell lines and standardized protocols to measure cytotoxicity, biological activity, and biochemical mechanisms for pharmaceutical research.

1 investor

Biofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care. It serves healthcare providers and partners, aiming to reduce hospital readmissions and cost of care.

1 investor

BioGaia develops and markets probiotic supplements for consumer health, with a particular focus on infant nutrition. The company manufactures most products in-house in Sweden and distributes globally to healthcare professionals and consumers.

1 investor

Biogaran is a French pharmaceutical brand focused on generic medicines and health products, offering health-related content and patient support initiatives. It serves patients and caregivers in France with wellness information and community programs.

1 investor

Biogazelle develops RNA biomarker discovery and transcriptome profiling solutions for clinical research and diagnostics. The company specializes in innovative RNA analysis technologies for medical applications.

1 investor

BIOGENA develops premium micronutrient supplements, functional drinks, and longevity services for consumer health and wellness across different life stages. The company manufactures products in Austria focused on scientific efficacy, purity, and quality standards.

1 investor

Biogenera develops BGA002, an anti-tumor therapeutic candidate targeting neuroblastoma and rhabdomyosarcoma, which primarily affect children and adolescents. The company is advancing the drug through clinical development with a structured regulatory pathway in Europe.

1 investor

Biogenes Technologies designs, develops, and commercializes animal-free aptamers for use in life science and diagnostics applications.

1 investor

Biognosys provides proteomics contract research services and software for pharma and biotech companies to support R&D, clinical trials, and clinical decision making. It develops mass-spectrometry-based proteomics tools used across drug discovery and clinical development.

1 investor

Biogroup Fertilité operates a network of fertility and assisted reproduction centers providing in vitro fertilization, artificial insemination, and fertility preservation services to patients across multiple locations. The company emphasizes standardized protocols, safety systems, and scientific innovation in reproductive medicine.

1 investor

BioGX is a manufacturer of molecular diagnostic tests. The company is a diagnostic test manufacturer, not a testing laboratory.

1 investor

Imviva is a clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases. The company focuses on creating safer, more effective off-the-shelf cell therapies designed to improve patient access and outcomes in regenerative medicine.

1 investor

BioHive is an organization supporting Utah's life sciences industry, coordinating community, communications, and returnship programs for the sector. It operates in the state of Utah, United States.

1 investor